|
Supplemental Guarantor Condensed Consolidating Financial Statements - Schedule of Consolidating Statement of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
|
Sep. 28, 2013
|
Sep. 29, 2012
|
Sep. 24, 2011
|
| Operating activities |
|
|
|
| Net cash provided by operating activities |
$ 493,822 |
$ 370,222 |
$ 456,024 |
| Investing activities |
|
|
|
| Acquisition of businesses |
(6,273) |
|
|
| Acquisition of business, net of cash acquired |
(6,273) |
(3,762,403) |
(198,744) |
| Payment of additional acquisition consideration |
(16,808) |
(9,784) |
(19,660) |
| Divestiture activities, net of cash transferred |
85,134 |
|
2,267 |
| Purchase of property and equipment |
(48,954) |
(33,149) |
(27,785) |
| Increase in equipment under customer usage agreements |
(41,176) |
(45,624) |
(27,878) |
| Purchase of insurance contracts |
(4,000) |
|
(5,322) |
| Proceeds from sale of intellectual property |
60,000 |
12,500 |
13,250 |
| Purchase of licensed technology and other intangible assets |
|
|
(3,021) |
| Acquisition of in-process research and development assets |
|
(4,500) |
|
| Purchase of cost-method investment |
(3,725) |
(250) |
(99) |
| Sale of cost-method investments |
2,104 |
|
|
| Increase in restricted cash |
|
|
405 |
| Investment in subsdiaries |
|
|
|
| Increase in other assets |
(7,548) |
(7,574) |
405 |
| Net cash provided by (used in) investing activities |
18,754 |
(3,850,784) |
(266,587) |
| Financing activities |
|
|
|
| Repayment of long-term debt |
(265,000) |
|
(1,362) |
| Proceeds from long-term debt |
|
3,476,320 |
|
| Payment of debt issuance cost |
(9,440) |
(81,408) |
(5,327) |
| Payment of contingent consideration |
(42,958) |
(51,680) |
(4,294) |
| Deferred acquisition consideration |
(1,655) |
|
|
| Payment of deferred acquisition consideration |
(1,655) |
(44,223) |
|
| Net proceeds from issuance of common stock pursuant to employee stock plans |
75,100 |
28,594 |
25,404 |
| Excess tax benefit related to equity awards |
7,439 |
6,206 |
3,652 |
| Payment of employee restricted stock minimum tax withholdings |
(12,256) |
(5,710) |
(10,399) |
| Intercompany dividend |
|
|
|
| Net cash (used in) provided by financing activities |
(248,770) |
3,328,099 |
7,674 |
| Effect of exchange rate changes on cash and cash equivalents |
(1,746) |
561 |
(404) |
| Net (decrease) increase in cash and cash equivalents |
262,060 |
(151,902) |
196,707 |
| Cash and cash equivalents, beginning of period |
560,430 |
712,332 |
515,625 |
| Cash and cash equivalents, end of period |
822,490 |
560,430 |
712,332 |
|
Parent Company/Issuer [Member]
|
|
|
|
| Operating activities |
|
|
|
| Net cash provided by operating activities |
237,354 |
236,063 |
431,353 |
| Investing activities |
|
|
|
| Acquisition of businesses |
(6,053) |
|
|
| Acquisition of business, net of cash acquired |
|
(3,971,970) |
(240,917) |
| Payment of additional acquisition consideration |
(16,808) |
(8,858) |
(19,660) |
| Divestiture activities, net of cash transferred |
|
|
1,138 |
| Purchase of property and equipment |
(15,480) |
(13,247) |
(11,512) |
| Increase in equipment under customer usage agreements |
(464) |
|
(1,121) |
| Purchase of insurance contracts |
(4,000) |
|
(5,322) |
| Proceeds from sale of intellectual property |
|
|
750 |
| Purchase of licensed technology and other intangible assets |
|
|
|
| Acquisition of in-process research and development assets |
|
(4,500) |
|
| Purchase of cost-method investment |
(3,500) |
|
|
| Sale of cost-method investments |
2,104 |
|
|
| Increase in restricted cash |
|
|
|
| Investment in subsdiaries |
|
|
|
| Increase in other assets |
(2,097) |
(558) |
|
| Net cash provided by (used in) investing activities |
(46,298) |
(3,999,133) |
(276,644) |
| Financing activities |
|
|
|
| Repayment of long-term debt |
(265,000) |
|
|
| Proceeds from long-term debt |
|
3,476,320 |
|
| Payment of debt issuance cost |
(9,440) |
(81,408) |
(5,327) |
| Payment of contingent consideration |
(42,958) |
(51,680) |
(4,294) |
| Deferred acquisition consideration |
(1,655) |
|
|
| Payment of deferred acquisition consideration |
|
(44,223) |
|
| Net proceeds from issuance of common stock pursuant to employee stock plans |
75,100 |
28,594 |
25,404 |
| Excess tax benefit related to equity awards |
7,439 |
6,206 |
3,652 |
| Payment of employee restricted stock minimum tax withholdings |
(12,256) |
(5,710) |
(10,399) |
| Intercompany dividend |
169,209 |
|
|
| Net cash (used in) provided by financing activities |
(79,561) |
3,328,099 |
9,036 |
| Effect of exchange rate changes on cash and cash equivalents |
|
302 |
48 |
| Net (decrease) increase in cash and cash equivalents |
111,495 |
(434,669) |
163,793 |
| Cash and cash equivalents, beginning of period |
210,028 |
644,697 |
480,904 |
| Cash and cash equivalents, end of period |
321,523 |
210,028 |
644,697 |
|
Guarantor Subsidiaries [Member]
|
|
|
|
| Operating activities |
|
|
|
| Net cash provided by operating activities |
205,034 |
104,167 |
9,040 |
| Investing activities |
|
|
|
| Acquisition of businesses |
|
|
|
| Acquisition of business, net of cash acquired |
|
196,771 |
9,070 |
| Payment of additional acquisition consideration |
|
|
|
| Divestiture activities, net of cash transferred |
83,646 |
|
|
| Purchase of property and equipment |
(23,345) |
(12,444) |
(8,646) |
| Increase in equipment under customer usage agreements |
(24,443) |
(30,735) |
(17,361) |
| Purchase of insurance contracts |
|
|
|
| Proceeds from sale of intellectual property |
60,000 |
12,500 |
12,500 |
| Purchase of licensed technology and other intangible assets |
|
|
(3,021) |
| Acquisition of in-process research and development assets |
|
|
|
| Purchase of cost-method investment |
(225) |
(250) |
(99) |
| Sale of cost-method investments |
|
|
|
| Increase in restricted cash |
|
|
|
| Investment in subsdiaries |
1,812 |
|
|
| Increase in other assets |
(4,209) |
(2,230) |
|
| Net cash provided by (used in) investing activities |
93,236 |
163,612 |
(7,557) |
| Financing activities |
|
|
|
| Repayment of long-term debt |
|
|
(1,362) |
| Proceeds from long-term debt |
|
|
|
| Payment of debt issuance cost |
|
|
|
| Payment of contingent consideration |
|
|
|
| Deferred acquisition consideration |
|
|
|
| Payment of deferred acquisition consideration |
|
|
|
| Net proceeds from issuance of common stock pursuant to employee stock plans |
|
|
|
| Excess tax benefit related to equity awards |
|
|
|
| Payment of employee restricted stock minimum tax withholdings |
|
|
|
| Intercompany dividend |
(175,000) |
|
|
| Net cash (used in) provided by financing activities |
(175,000) |
|
(1,362) |
| Effect of exchange rate changes on cash and cash equivalents |
(5,264) |
1,637 |
(121) |
| Net (decrease) increase in cash and cash equivalents |
118,006 |
269,416 |
|
| Cash and cash equivalents, beginning of period |
269,416 |
|
|
| Cash and cash equivalents, end of period |
387,422 |
269,416 |
|
|
Non-Guarantor Subsidiaries [Member]
|
|
|
|
| Operating activities |
|
|
|
| Net cash provided by operating activities |
51,434 |
29,992 |
15,631 |
| Investing activities |
|
|
|
| Acquisition of businesses |
(220) |
|
|
| Acquisition of business, net of cash acquired |
|
12,796 |
33,103 |
| Payment of additional acquisition consideration |
|
(926) |
|
| Divestiture activities, net of cash transferred |
1,488 |
|
1,129 |
| Purchase of property and equipment |
(10,129) |
(7,458) |
(7,627) |
| Increase in equipment under customer usage agreements |
(16,269) |
(14,889) |
(9,396) |
| Purchase of insurance contracts |
|
|
|
| Proceeds from sale of intellectual property |
|
|
|
| Purchase of licensed technology and other intangible assets |
|
|
|
| Acquisition of in-process research and development assets |
|
|
|
| Purchase of cost-method investment |
|
|
|
| Sale of cost-method investments |
|
|
|
| Increase in restricted cash |
|
|
405 |
| Investment in subsdiaries |
(1,812) |
|
|
| Increase in other assets |
(1,242) |
(4,786) |
|
| Net cash provided by (used in) investing activities |
(28,184) |
(15,263) |
17,614 |
| Financing activities |
|
|
|
| Repayment of long-term debt |
|
|
|
| Proceeds from long-term debt |
|
|
|
| Payment of debt issuance cost |
|
|
|
| Payment of contingent consideration |
|
|
|
| Deferred acquisition consideration |
|
|
|
| Payment of deferred acquisition consideration |
|
|
|
| Net proceeds from issuance of common stock pursuant to employee stock plans |
|
|
|
| Excess tax benefit related to equity awards |
|
|
|
| Payment of employee restricted stock minimum tax withholdings |
|
|
|
| Intercompany dividend |
5,791 |
|
|
| Net cash (used in) provided by financing activities |
5,791 |
|
|
| Effect of exchange rate changes on cash and cash equivalents |
3,518 |
(1,378) |
(331) |
| Net (decrease) increase in cash and cash equivalents |
32,559 |
13,351 |
32,914 |
| Cash and cash equivalents, beginning of period |
80,986 |
67,635 |
34,721 |
| Cash and cash equivalents, end of period |
113,545 |
80,986 |
67,635 |
|
Eliminations [Member]
|
|
|
|
| Operating activities |
|
|
|
| Net cash provided by operating activities |
|
|
|
| Investing activities |
|
|
|
| Acquisition of businesses |
|
|
|
| Acquisition of business, net of cash acquired |
|
|
|
| Payment of additional acquisition consideration |
|
|
|
| Divestiture activities, net of cash transferred |
|
|
|
| Purchase of property and equipment |
|
|
|
| Increase in equipment under customer usage agreements |
|
|
|
| Purchase of insurance contracts |
|
|
|
| Proceeds from sale of intellectual property |
|
|
|
| Purchase of licensed technology and other intangible assets |
|
|
|
| Acquisition of in-process research and development assets |
|
|
|
| Purchase of cost-method investment |
|
|
|
| Sale of cost-method investments |
|
|
|
| Increase in restricted cash |
|
|
|
| Investment in subsdiaries |
|
|
|
| Increase in other assets |
|
|
|
| Net cash provided by (used in) investing activities |
|
|
|
| Financing activities |
|
|
|
| Repayment of long-term debt |
|
|
|
| Proceeds from long-term debt |
|
|
|
| Payment of debt issuance cost |
|
|
|
| Payment of contingent consideration |
|
|
|
| Deferred acquisition consideration |
|
|
|
| Payment of deferred acquisition consideration |
|
|
|
| Net proceeds from issuance of common stock pursuant to employee stock plans |
|
|
|
| Excess tax benefit related to equity awards |
|
|
|
| Payment of employee restricted stock minimum tax withholdings |
|
|
|
| Intercompany dividend |
|
|
|
| Net cash (used in) provided by financing activities |
|
|
|
| Effect of exchange rate changes on cash and cash equivalents |
|
|
|
| Net (decrease) increase in cash and cash equivalents |
|
|
|
| Cash and cash equivalents, beginning of period |
|
|
|
| Cash and cash equivalents, end of period |
|
|
|